Share
10,917 Posts.
lightbulb Created with Sketch. 45
clock Created with Sketch.
03/10/23
10:36
Share
Originally posted by TheAnalyst007:
↑
Nova Eye Medical (EYE) - should see 100% growth in revenue this FY on a c. $20m base due to the launch of a new best in class device into the high growth minimally invasive glaucoma surgery (MIGS) market. Only a $38m market cap, very cheap compared to peers, assets and revenue Gross margins of 80%, with a bit of scale this should be breakeven next year and highly profitable in 2-3 years from now Solid management, pays themselves little compensation relative to other companies on the ASX Loaded with cash (relative to the small current cash burn). Unlikely to need to raise capital in the future due to profitability expected soon Exciting R&D pipeline as well for future growth sources
Expand
Yes looks interesting EYE last financial year revenue was up 27% in a growing market.So if they can achieve that rate of growth and even better the company is heading in the right direction.